Celltrion unveils world's first quadruple-action obesity drug, plans global trials next year
The Korean company claims its four-hormone candidate beats triple-action rivals while preserving muscle, positioning it in the crowded obesity race.
Read at λ¨Έλν¬λ°μ΄ βFull coverage Β· 7 outlets
- λ¨Έλν¬λ°μ΄ Β· lead
- ChosunbizCelltrion touts four-hormone obesity drug that tops triple-action rival
- μμμκ²½μ Celltrion Unveils Quadruple-Action Obesity Drug Candidate for First Time: "Weight Loss with Less Muscle Loss"
- Seoul Economic DailyCelltrion Unveils Preclinical Data on Quadruple-Action Obesity Drug
- μ‘°μ μΌλ³΄Celltrion to Unveil Quadruple-Action Obesity Drug in November
- finance.biggo.comCelltrion Begins Primate Toxicity Tests for Quadruple-Action Obesity Drug, Targets IND Filing in First Half of Next Year
- MtCelltrion unveils results for world's first 'quadruple-action' obesity drug, plans global trials next year